Specialty Infusion Provider to Continue Growth into New Markets and Therapies
Ridgemont Equity Partners, a buyout and growth equity investor, announced the acquisition of American Outcomes Management (“AOM” or the “Company”), a leading specialty infusion provider focused on intravenous immunoglobulin (“IVIG”) infusion therapy. Financial terms of the transaction were not disclosed.
Latest Aithority Insights: Fivetran Extends Market-Leading Position; More Than Doubles Revenue in 2021
“AOM has a tremendous growth opportunity ahead and several avenues for expansion”
AOM provides home-based IVIG therapy to patients with over 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The Company also provides support services, including pharmacy services, referral management, insurance verification and patient education and training. AOM was founded in 1994 and holds pharmacy licenses in all 50 states.
“Specialty infusion services have been a focus area for Ridgemont for many years,” said Petri Lindberg, Principal at Ridgemont. “It is a very large and growing market, driven by an aging population suffering from chronic conditions, a significant pipeline of specialty infusion drugs and increased adoption of at-home treatment. AOM is a scaled platform with a strong market position, best-in-class reputation in multiple key metro areas and dedicated focus on high quality infusion services. We are excited to partner with Chris York, a seasoned executive with decades of experience in the home infusion sector and longtime operating advisor to Ridgemont.”
Browse The Complete News About Aithority: LiveRamp Collaborates with Adobe to Enable Omnichannel People-based Targeting and Measurement
“AOM has a tremendous growth opportunity ahead and several avenues for expansion,” said Chris York, Chairman of AOM. “Our vision for the business starts with investing in our team and capabilities to expand our presence in all geographic markets and offer additional specialty infusion therapies. Infusion services continue to shift out of the hospital setting towards alternative sites as patients, providers and payors prefer the comfort and cost-effectiveness of at-home treatment. With Ridgemont’s support, AOM can broaden its reach and help more people in our communities find long-term care solutions.”
Financing for the transaction was provided by AB Private Credit Investors and BMO Sponsor Finance. Houlihan Lokey Capital, Inc., served as financial advisor to Ridgemont. McDermott Will & Emery LLP and Clark Hill PLC provided legal services for Ridgemont and AOM, respectively.
Read More About Aithority News : Vertica and H3C ONEStor Bring Cloud-Scale Analytics to Enterprise Data Centers
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.